We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.4B
AUM Growth
-$526M
Cap. Flow
+$279M
Cap. Flow %
1.3%
Top 10 Hldgs %
19.79%
Holding
3,307
New
142
Increased
1,419
Reduced
1,480
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.11%
2 Financials 4.79%
3 Consumer Discretionary 4.07%
4 Healthcare 3.88%
5 Industrials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFX
3076
DELISTED
BowFlex Inc.
BFX
$23K ﹤0.01%
26,599
+1,481
+6% +$1.46K
REI icon
3077
Ring Energy
REI
$354M
$22K ﹤0.01%
11,300
ZOM
3078
DELISTED
Zomedica Corp.
ZOM
$22K ﹤0.01%
129,080
-11,128,480
-99% -$2.16M
BRFS
3079
DELISTED
BRF SA
BRFS
$21K ﹤0.01%
10,000
PHIO icon
3080
Phio Pharmaceuticals
PHIO
$12.5M
$21K ﹤0.01%
1,581
VFF icon
3081
Village Farms International
VFF
$307M
$21K ﹤0.01%
25,948
+933
+4% +$716
BFLY icon
3082
Butterfly Network
BFLY
$2.52B
$20K ﹤0.01%
17,283
-11,524
-40% -$22.3K
SGMO
3083
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$19K ﹤0.01%
30,854
OTLY
3084
Oatly Group
OTLY
$420M
$18K ﹤0.01%
997
-402
-29% -$11.7K
RENT
3085
Rent the Runway
RENT
$119M
$18K ﹤0.01%
1,356
+550
+68% +$15.7K
WKHS icon
3086
Workhorse Group
WKHS
$33.7M
$18K ﹤0.01%
15
+3
+25% +$7.71K
CLOV icon
3087
Clover Health Investments
CLOV
$2.41B
$17K ﹤0.01%
16,195
-3,728
-19% -$4.43K
GSAT icon
3088
Globalstar
GSAT
$10.8B
$17K ﹤0.01%
847
+138
+19% +$2.48K
GEVO icon
3089
Gevo
GEVO
$391M
$16K ﹤0.01%
13,238
-510
-4% -$754
HRTX icon
3090
Heron Therapeutics
HRTX
$64.7M
$16K ﹤0.01%
15,617
-1,900
-11% -$2.7K
LXRX icon
3091
Lexicon Pharmaceuticals
LXRX
$1.05B
$16K ﹤0.01%
+14,239
New +$25K
QVCGA
3092
DELISTED
QVC Group Inc Series A
QVCGA
$16K ﹤0.01%
531
-93
-15% -$3.92K
VAXX
3093
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$16K ﹤0.01%
12,000
-11
-0.1% -$24
SPRU icon
3094
Spruce Power Holding Corp
SPRU
$38.9M
$15K ﹤0.01%
2,815
+119
+4% +$791
AKTS
3095
DELISTED
Akoustis Technologies Inc
AKTS
$15K ﹤0.01%
19,442
DMTK
3096
DELISTED
DermTech, Inc. Common Stock
DMTK
$15K ﹤0.01%
+10,241
New +$25.6K
SOLO
3097
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$15K ﹤0.01%
22,188
CLSD
3098
DELISTED
Clearside Biomedical
CLSD
$14K ﹤0.01%
1,100
-67
-6% -$1.01K
RJET
3099
Republic Airways Holdings
RJET
$962M
$14K ﹤0.01%
1,099
-233
-17% -$6.05K
DXYN
3100
DELISTED
Dixie Group Inc
DXYN
$14K ﹤0.01%
20,000

Similar funds

Cambridge Investment Research Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Cambridge Investment Research Advisors held 3,307 positions worth $21.4B, down 2.4% from $21.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q3 2023 filing shows 142 new, 1,419 increased, 1,480 reduced and 171 closed positions. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2023 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M.
  • Cambridge Investment Research Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q3 2023, an estimated $69.3M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $46.5M.
  • Cambridge Investment Research Advisors fully exited Invesco S&P SmallCap Quality ETF in Q3 2023, selling an estimated $4.88M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.4B portfolio in Q3 2023.
  • Cambridge Investment Research Advisors opened 142 new positions and closed 171 in Q3 2023.
  • Cambridge Investment Research Advisors's portfolio value fell 2.4% quarter-over-quarter to $21.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.